February 06, 2025
Los Angeles, California
Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 creditsAn Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
0.50 creditsPreventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
0.50 creditsLDL-C Management Trends in ASCVD Patients
LDL-C Management Trends in ASCVD Patients
February 06, 2025
Los Angeles, California
Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
February 13, 2025
San Francisco, California
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
0.50 creditsPoster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
February 13, 2025
07:30 PM - 09:00 PM PT
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
February 14, 2025
San Francisco, California
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
AI-Powered Virtual Hospital in China to Launch Public Pilot in 2025
AI-Powered Virtual Hospital in China to Launch Public Pilot in 2025
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Holistic AI Models Revolutionizing Cancer Detection and Treatment
The Potential of AI Language Translation Tools for Addressing Healthcare Inequities
The Potential of AI Language Translation Tools for Addressing Healthcare Inequities
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
New AI Dataset Advances Dermatology for Darker Skin Tones
New AI Dataset Advances Dermatology for Darker Skin Tones
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
0.25 creditsNew Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
0.75 creditsClinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
1.25 program creditsCardiorenal Collaboration: Escape the Treatment Trap
Cardiorenal Collaboration: Escape the Treatment Trap
1.00 creditsDecoding CIDP: Exploring Common and Atypical Variants
Decoding CIDP: Exploring Common and Atypical Variants
1.00 program creditsClinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
1.25 program creditsTreating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Objective Measures and Endoscopic Improvement
Objective Measures and Endoscopic Improvement
Advancements in Understanding ALS Treatment
Advancements in Understanding ALS Treatment
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Investigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO
Investigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO